Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 12.09 is in line with its 5-year average of 13.14, around the middle of its 5-year range (4.80–24.58).
24.45% above its 12-month average of 9.71.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 3.66.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:15:46.919Z. Historical observations retain their original dates. Historical series through 2026-09-10.
EARNINGS PER SHARE (EPS)
12.09
EARNINGS PER SHARE (EPS) AVG TTM
9.71
EARNINGS PER SHARE (EPS) AVG 3Y
9.57
EARNINGS PER SHARE (EPS) AVG 5Y
13.14
EARNINGS PER SHARE (EPS) AVG 10Y
10.90
EARNINGS PER SHARE (EPS) AVG 15Y
8.34
EARNINGS PER SHARE (EPS) AVG 20Y
6.79
CURRENT VS TTM AVG
+24.45%
CURRENT VS 3Y AVG
+26.37%
CURRENT VS 5Y AVG
-7.99%
CURRENT VS 10Y AVG
+10.91%
CURRENT VS 15Y AVG
+45.01%
CURRENT VS 20Y AVG
+77.93%
Labcorp Holdings Inc.
Market Cap
$25.55B
Earnings Per Share (EPS)
12.09
TTM Avg
9.71
3Y Avg
9.57
5Y Avg
13.14
Market Cap
$25.94B
Earnings Per Share (EPS)
9.42
TTM Avg
8.33
3Y Avg
8.09
5Y Avg
9.83
Market Cap
$26.14B
Earnings Per Share (EPS)
44.49
TTM Avg
41.42
3Y Avg
39.43
5Y Avg
36.04
Market Cap
$24.62B
Earnings Per Share (EPS)
7.85
TTM Avg
3.38
3Y Avg
2.74
5Y Avg
2.31
Market Cap
$24.37B
Earnings Per Share (EPS)
7.82
TTM Avg
6.79
3Y Avg
7.36
5Y Avg
7.17
Market Cap
$28.88B
Earnings Per Share (EPS)
3.45
TTM Avg
4.46
3Y Avg
4.05
5Y Avg
4.25
Market Cap
$21.10B
Earnings Per Share (EPS)
27.91
TTM Avg
28.29
3Y Avg
23.40
5Y Avg
19.31
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. (LH) | $25.55B | 12.09 | 9.71 | 9.57 | 13.14 |
| Quest Diagnostics Incorporated (DGX)vs › | $25.94B | 9.42 | 8.33 | 8.09 | 9.83 |
| Mettler-Toledo International Inc. (MTD)vs › | $26.14B | 44.49 | 41.42 | 39.43 | 36.04 |
| Incyte Corporation (INCY)vs › | $24.62B | 7.85 | 3.38 | 2.74 | 2.31 |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.37B | 7.82 | 6.79 | 7.36 | 7.17 |
| BioNTech SE (BNTX)vs › | $24.30B | -7.76 | -4.08 | 9.21 | 14.48 |
| Medline Inc. (MDLN)vs › | $27.51B | 0.86 | 1.48 | 0.80 | 0.80 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $28.88B | 3.45 | 4.46 | 4.05 | 4.25 |
| United Therapeutics Corporation (UTHR)vs › | $21.10B | 27.91 | 28.29 | 23.40 | 19.31 |
| Waters Corporation (WAT)vs › | $30.54B | 4.01 | 10.78 | 11.05 | 10.65 |
Trailing EPS (TTM)
$12.09
Forward EPS (Est.)
$18.35
P/E Ratio
25.8
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 10.54 |
| 2024-12-31 | 8.89 |
| 2023-12-31 | 4.80 |
| 2022-12-31 | 14.04 |
| 2021-12-31 | 24.58 |
| 2020-12-31 | 15.99 |
| 2019-12-31 | 8.41 |
| 2018-12-31 | 8.71 |
| 2017-12-31 | 12.39 |
| 2016-12-31 | 7.14 |
| 2015-12-31 | 4.42 |
| 2014-12-31 | 6.03 |
| 2013-12-31 | 6.70 |
| 2012-12-31 | 6.24 |
| 2011-12-31 | 5.31 |
| 2010-12-31 | 5.45 |
| 2009-12-31 | 4.98 |
| 2008-12-31 | 4.60 |
| 2007-12-31 | 4.08 |
| 2006-12-31 | 3.48 |
| 2005-12-31 | 2.89 |
| 2004-12-31 | 2.60 |
| 2003-12-31 | 2.23 |
| 2002-12-31 | 1.78 |
| 2001-12-31 | 1.29 |
| 2000-12-31 | 0.83 |
| 1999-12-31 | 0.30 |
| 1998-12-31 | 0.50 |
| 1997-12-31 | -2.17 |
| 1996-12-31 | -3.12 |
